Cheek augmentation market is expected to grow owing to the increasing demand for cosmetic procedures, adoption of technological advancements, rising medical tourism, and the growing aging population. These are three products, which include dermal fillers, implants, and others. The rising adoption of minimally invasive surgeries and rising influence through social media increases the demand for the market growth of cheek augmentation during the forecast period.
According to The American Society of Plastic Surgeons, in 2020, there have been 108,189 procedures of cheek implants solely on females. Moreover, nearly 108,189 cheek implant procedures for men took place. Approximately, 216,350 and 28,638 facelift procedures were performed in the same year on females and males respectively. The aging population has been a significant driver of the cheek augmentation market. As people age, their skin loses elasticity, resulting in sagging cheeks and other signs of aging. Cheek augmentation can help to restore a more youthful appearance, making it an attractive option for older individuals. According to a survey, by WebMD LLC in November 2021, approximately 75% of individuals above the age of 65 years are open to getting plastic surgery. According to IBIS World, in 2023, there are around 12,112 plastic surgery clinics opened in the U.S., which is an increase of 2% compared to 2022.
Based on the product, dermal fillers is expected to dominate the market due to rising demand for minimally invasive surgeries. Moreover, dermal fillers are quick and easy to administer, with many treatments taking less than an hour to complete making it a convenient option for individuals. In addition, dermal fillers are versatile and can be customized to suit the individual needs of the patient’s requirement. A skilled professional uses dermal fillers to create a wide range of effects, from subtle enhancements to more vivid changes.
The North American region is expected to witness the largest market share and growth over the forecast period. The factors such as high technological advances, rising demand for cosmetic procedures, growing developments in healthcare infrastructure, and rising geriatric population contributes to the growth of the cheek augmentation market. Moreover, a strong regulatory framework, which includes US Food and Drug Administration (FDA) and Health Canada in the region ensures the safety and effectiveness of cosmetic procedures.
Medical procedures make people travel to different countries for better treatment at affordable prices. Cosmetic surgery at a lower cost is an extremely popular choice in medical tourism. Research article shows that having surgery abroad saves approximately 40-80% of the total cost. The top 10 destinations for getting cosmetic surgery are Brazil, Japan, Italy, Mexico, Russia, India, Turkey, Germany, and France.
These FDA approvals, collaborations, mergers, and acquisitions are expected to boost the cheek augmentation market growth over the forecast period. Leading participants in the cheek augmentation market that provides products and services includes Allergan, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Sientra, Inc., Johnson & Johnson Services, Inc., Sinclair Pharma PLC, Cutera, Inc., and Anika Therapeutics, Inc. among others.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."